Severe interstitial pneumonia due to murine typhus in a patient returning from Bali by Malheiro, Luís et al.
Contents lists available at ScienceDirect
IDCases
journal homepage: www.elsevier.com/locate/idcases
Case report
Severe interstitial pneumonia due to murine typhus in a patient returning
from Bali
Luís Malheiroa,b,⁎, Filipa Ceiaa, João Alvese, Ana Cláudia Carvalhoa, Joana Sobrinho-Simõesc,
Rita Sousad, António Sarmentoa,b, Lurdes Santosa,b
a Serviço de Doenças Infecciosas (Infectious Diseases Department), Centro Hospitalar de S. João, Porto, Portugal
b Unidade de Cuidados Intensivos de Doenças Infeciosas (Intensive Care Unit of Infectious Diseases), Centro Hospitalar de S. João, Porto, Portugal
c Clinical Microbiology Department, Centro Hospitalar de S. João, Porto, Portugal
d Instituto Nacional de Saúde Doutor Ricardo Jorge (National Institute of Health Doutor Ricardo Jorge), Centro de Estudos de Vectores e Doenças Infecciosas Dr. Francisco
Cambournac (CEVDI) (Center for Vectors and Infectious Disease Research (CEVDI) and Gastrointestinal Infections Laboratory), Aguas de Moura, Portugal
e Serviço de Doenças Infecciosas e Medicina Tropical, Hospital de Egas Moniz, Centro Hospitalar de Lisboa Ocidental, E.P.E., Lisboa, Portugal
A B S T R A C T
Murine typhus has been increasingly reported as a cause of fever in returning travelers from Southeast Asia. We
report a case of a previously healthy traveler returning from Bali with an non-speciﬁc febrile illness which
quickly progressed to a severe form of interstitial pneumonia. After a careful epidemiological evaluation and
laboratory analysis, murine typhus was diagnosed.
Due to their non-speciﬁc presentations, most febrile illnesses in
returning travelers are hard to diagnose clinically. While many of them
are self-limited, others like malaria, dengue and typhoid fever require
speciﬁc treatment due to their complications and must be quickly
excluded. Some diseases like murine typhus, require a high level of
suspicion and careful epidemiologic evaluation to be diagnosed, as
sometimes they may present in severe forms. Awareness is important,
especially in countries where the disease is not endemic and may be not
included in the diﬀerential diagnosis. We draw attention to murine
typhus as an important diﬀerential diagnosis in travelers returning from
Southeast Asia and to its uncommon, but important, pulmonary
complications.
Introduction
Murine typhus is a systemic disease caused by Rickettsia typhi, a
Typhus group bacteria from the Rickettsiaceae family, transmitted to the
human by the rat ﬂea Xenopsilla cheopsis [1]. The reservoirs are two
murine rodents known as the brown (Rattus norvegicus) and black
(Rattus rattus) rat [2]. As the reservoirs and vector are common in most
countries, the disease is spread worldwide, especially in temperate
climates and coastal/harbor areas, depending on rodent control pro-
grams and hygiene standards. Murine typhus is mainly characterized by
a mild self-limited syndrome with fever, myalgia and headache,
although some severe manifestations as pneumonitis, hepatitis and
meningoencephalitis may also occur.
In Portugal, murine typhus incidence is unknown [3]. It may be a
relevant diﬀerential diagnosis due to potential complications, especially
in the traveler presenting with fever coming from an endemic country
such as those in Southeast Asia. We present a case of a traveler
returning from Bali, an Indonesian island in the Paciﬁc Ocean, with a
non-speciﬁc febrile illness complicated by severe interstitial pneumo-
nia.
Clinical report
A 38 year-old previously healthy woman returned from a 2 week-
long trip to Bali. She had no pre travel consultation and did not take any
malaria prophylaxis. During her stay, she travelled around rural areas
of the island where she had close contact with people living in poor
water and sanitation conditions. She mentioned seeing rats around the
accommodation and recalled several mosquito bites, apart from spora-
dic contact with dogs and cats, with no scratching or biting episodes.
She returned to Portugal asymptomatic, but a week after arrival she
presented to the emergency department complaining of fever, chills,
malaise, myalgia and conjunctival congestion. Her initial blood tests
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(Table 1-Day 1) showed unremarkable changes. Chest X-Ray (Fig. 1a)
was normal. Initial investigations for malaria and dengue were negative
and she was discharged home with symptomatic treatment with
acetaminophen. Forty-eight hours later the patient was re-evaluated
in ambulatory and fever persisted, along with malaise and myalgia. Her
general condition was good and physical examination was normal.
At this point, her blood tests presented relative neutrophilia,
elevated hepatic aminotransferases and elevated LDH, with mildly
increased C-reactive protein (Table 1-Day 3). Chest X-ray and abdom-
inal ultrasonography had no abnormalities. Two blood samples were
collected for culture in aerobic conditions and a ﬁrst serologic screen
was requested (Table 2). The patient was admitted to the Infectious
Diseases Ward for observation.
On the 1st day after admission (day 4 of symptoms) her clinical and
analytical condition deteriorated with shortness of breath (respiratory
rate of 32/minute, SatO2 90–92% on room air), hypotension (70–80/
30–40 mmHg), headache, nausea and a faint, transient, macular rash in
the abdomen, trunk and arms. She looked acutely ill. Arterial blood gas
examination revealed a respiratory alkalosis with a pO2/FiO2 ratio of
327 and hyperlactacidemia (2.88 mg/dL). Her chest X-ray (Fig. 1b)
revealed a bilateral interstitial inﬁltrate in the lung parenchyma
suggestive of interstitial pneumonia.
The patient was admitted to the Intensive Care Unit (ICU) with
volume expansion with Intravenous (IV) ﬂuids, IV ceftriaxone (2 g per
day), IV doxycycline (100 mg twice daily) and oseltamivir (75 mg twice
daily). Oxygen support was delivered by high ﬂux nasal prongs. At this
point, new microbiological exams were requested (Table 2).
While in the ICU, the patient condition improved progressively,
with no need of invasive ventilation or vasopressive support. Oliguria
was reverted. There was a transient decrease in hemoglobin and
worsening thrombocytopenia and coagulopathy, which recovered
spontaneously. The patient became afebrile by the 4th day of anti-
microbial, was discharged from ICU on day 5 and fully recovered by the
7th day of antimicrobials (10th day of disease). Ceftriaxone was given
for 8 days, while doxycycline was given for a total of 14 days (7 days by
IV route and 7 days by oral route).
At discharge from the hospital (day 13), the patient was asympto-
matic. Chest X-ray (Fig. 1c) conﬁrmed resolution of the pulmonary
inﬁltrates. A molecular diagnostic test using polymerase chain reaction
(PCR) for Rickettsia spp. subgroup Typhus was later found to be positive.
All other microbiological exams were negative.
To conﬁrm the diagnosis of R. typhi infection, serum samples from
acute (day 4 of disease) and convalescent (2 weeks after discharge)
phases were sent to the Center for Vectors and Infectious Disease
Research (Centro de Estudos de Vectores e Doenças Infecciosas – CEVDI) of
the National Institute of Health in Águas de Moura, Setúbal, Portugal,
were they were tested by immunoﬂuorescence assay using a commer-
cial Rickettsia IFA Substrate Slide kit® (Focus Diagnostics, USA).
Seroconversion in two consecutive samples of the patient was demon-
strated by the appearance of antibodies levels in second sample with
Table 1
Blood analysis results. Legend: ALT – alanine aminotransferase; AP – Alcaline Phosphatase; AST – aspartate aminotransferase; B – Bilirrubin; DB – direct bilirrubina; CK – creatinine
kinase; CRP – C-reactive protein; Eos – Eosinophyles; gGT – Gamma glutamyl transpeptidase; Hb – Hemoglobin; Leuc. – Leucocytes; LDH – Lactate desidrogenase; Lym – Lymphocytes;
Neu – Neutrophiles; PLT – Platelets; SCr – serum creatinine; U – urea.
Range Day 1 Day 3 Day 4 Day 5 Day 7 Day 9 Day 11 Day 23
Hb (g/dL) 12–16 12.9 13.1 12.2 13.0 11.5 9.8 11.9 11.2
Leuc (*10^9/uL) 4–11 4.850 4.970 6.540 5.59 15.10 13.12 12.29 9.03
Neu(%) 53-69 65.4 79.6 84.5 78.4 62.4 39.5 39.5 25.4
Lym(&) 22–36 24.1 7.7 12.2 14.1 29.2 41.5 41.4 62.4
Eos(%) 0.6−4.6 0.0 0.0 0.0 0.0 0.1 1.0 1.2 1.0
PLT(*10^9/uL) 150–400 265 135 69 51 60 193 403 636
ALT/AST (U/L) (10–31) 36/53 116/128 191/237 328/403 169/118 111/89 139/105 67/36
AP/gGT
(U/L)
(7–32/30−120) 109/25 167/73 175/80 187/91 204/69 349/122 445/212 155/69
B/DB (mg/dL) (< 1.2/< 0.4) 0.42/0.11 0.79/0.22 1.03/0.4 0.9/0.23 1.38/0.52 0.95/0.24 0.86/0.26 1.00/0.21
LDH (U/L) 135–255 297 351 507 677
CK (U/L) 10–149 110 95 105 127
SCr (mg/dL) 0.51−0.95 0.74 0.66 0.61 0.53 0.51 0.51 0.47 0.6
U (mg/dL) 10–50 32 30 19 17 31 29 19 25
CRP (mg/L) < 3.0 20.9 56.7 102 193 256 87.1 23.1
Fig. 1. a) Chest X-ray on the 1st day of fever; b) Chest X-ray on the 4th day of fever and on admission to the ICU; c) Chest X ray on the 7th day of antimicrobial.
L. Malheiro et al. IDCases 9 (2017) 17–20
18
endpoint titers for IgM of 2048 and for IgG of 4096.
Molecular detection for rickettsial DNA was performed in buﬀy coat
specimen. Brieﬂy, DNA was extracted using the commercial QIAamp
One-For-All Nucleic Acid Kit® (Qiagen, Hilden, Germany) according to
the manufacturer's recommendations. Nested – PCR was performed
targeting citrate synthase (gltA) gene fragment for Rickettsia spp. as
previously described [4]. Positive amplicons were sequence and edited
by using Lasergene software (DNASTAR, Madison, WI, USA).
Sequence characterization, performed by BLAST analysis, revealed
that the our sequence was closest to the corresponding sequence of R.
typhi, showing 99% (391/392) bp identity with gltA of R. typhi
sequences deposit in GeneBank with accessions numbers CP003398,
AE017197, U59714.
Conclusion
In Portugal, the only rickettsial disease of public health concern
with mandatory reporting is Mediterranean spotted fever (MSF) caused
by R. conorii. Murine typhus was common in Portugal in the 1950′s but
its incidence declined over time and there have been no reported cases
of murine typhus since 1998 [5]. Since murine typhus does not require
a mandatory report to public health authorities in Portugal, under-
reporting may occur.
Outside Europe, murine typhus is reported in Southeast Asia and
Central and South America, as well as many other countries where
sanitary conditions are still improving. There are no consistent data
from the African continent [6,7]. Although malaria, dengue and
typhoid fever lead as the main causes of fever in residents of southeast
Asia, it is well known that rickettsia infections follow as frequent causes
in that population, especially in rural areas and within refugee
population [8,9].
In the traveler returning from endemic areas and presenting with
fever, murine typhus should be considered in the diﬀerential diagnosis,
along with malaria, typhoid fever, leptospirosis, dengue, chikungunya
and other arboviruses. Contact with animals and visits to rural areas are
important epidemiological clues that may help in the diagnosis, as well
as knowledge on local disease patterns. In recent years, a few case
reports of murine typhus in travelers returning from Bali increased its
relevance as a diﬀerential diagnosis, although murine typhus is still
very rarely reported [10–12].
While asymptomatic in up to a third, the disease manifests in
60–70% of the cases as a mild febrile illness with musculoskeletal pain
and headache after a 1–2 weeks incubation period. Due to its non-
speciﬁc presentation, diagnosis relies on high index of clinical suspicion
and laboratory conﬁrmation. A macular or maculopapular rash of the
trunk and extremities may also develop on the 5th day of fever, usually
sparing palms and soles, the latter being a useful clinical feature to
distinguish murine typhus from spotted fever rickettsiosis. Murine
typhus may uncommonly (10%) present with organ-speciﬁc lesion such
as pneumonitis, hepatitis, meningoencephalitis, renal failure and septic
shock.
As seen in our patient, a recent review suggests that pulmonary
involvement in murine typhus may be more common than it was
thought, as there was a prevalence of radiological abnormalities in
16.7% in whom a chest radiograph was performed. Most abnormalities
consisted in bilateral or unilateral interstitial inﬁltrates. The pulmonary
changes in murine typhus may be associated with damaged pulmonary
microcirculation, but reports on respiratory distress or failure was only
found in 7 patients, 2 of which presented with an acute respiratory
distress syndrome (ARDS), with a fatal outcome. Most of the severe
cases with pulmonary manifestations originated in Asia, which may
reveal a pattern of geographic distribution of diﬀerent pathophysiolo-
gical manifestations [13].
Due to its non-speciﬁc presentation of fever, malaise and myalgia, it
may be misidentiﬁed as an inﬂuenza-like illness, or, if the epidemio-
logic context is compatible, as an non-speciﬁc febrile illness in the
Table 2
Microbiological results. Legend: Ab – Antibodies; Ag – Antigen; CMV – Cytomegalovirus; EBV – Epstein-Barr Virus; NAAT – Nucleic Acid Ampliﬁcation Test; NS1 – non-structural protein
1; SG1–Serogroup 1; TPPA – Treponema pallidum particle agglutination test.
Product Day 1 Day 3 Day 4 Day 5 Day 28
Blood cultures (each pair) Blood Negative Negative Negative
Urine culture Urine Negative
Plasmodium test (antigen and thin
smear)
Blood Negative Negative Negative
Dengue test (NS1 + Ab) Blood Negative Negative Negative
Dengue NAAT Blood Negative Negative
Chikungunya NAAT Blood Negative
Inﬂuenza A/B NAAT Nasal swab Negative
Leptospira spp. NAAT Blood Negative
Leptospira spp. NAAT Urine Negative
Heterophile Ab Blood Negative
CMV Ab Blood IgG +
EBV Ab Blood VCA IgM + Early IgG− EBNA
IgG + VCA IgG+
Coxiella burnetii Ab Blood Negative
Rickettsia conorii Ab Blood Negative
Borrelia spp. Ab Blood Negative
Toxoplasma spp. Ab Blood Negative
Treponemic test (TPPA) Blood Negative
Mycoplasma pneumoniae Blood Negative
Chlamydophila pneumoniae Blood Negative
Legionella pneumophila SG1 Ag Urine Negative
S. pneumoniae Ag Urine Negative
Hepatitis E NAAT Blood Negative
Rickettsia spp. NAAT Blood Positive for Rickettsia spp. group
typhus
Negative for Rickettsia spp. spotted
fever group
Rickettsia typhi NAAT Blood Positive
Rickettsia typhi Ab Blood Negative IgM 1:2048 IgG
1:4096
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returning traveler after excluding malaria and dengue in the emergency
department. However, even when considered as a diagnosis, laboratory
resources for the conﬁrmation of murine typhus are not widely
available.
This case is the ﬁrst identiﬁed case of murine typhus in Portugal
since 1998. Mortality of murine typhus ranges from 0 to 1%, but several
risk such as an older age, hematologic diseases and delays in the
diagnosis and antimicrobial treatment may contribute for a worse
prognosis. The main question that remains to be answered is why a
previously non-pregnant healthy woman, without smoking habits or
comorbidities, developed such an atypical and severe manifestation of
the disease. Some reasons for this presentation could have been a high
inoculum or a speciﬁc southeast strain of R. typhi. The delay in adequate
antimicrobial treatment and aggressive IV ﬂuid therapy for hypoten-
sion, may have also contributed for the ARDS. Whether this was an
isolated event or other reasons exist, should be answered in future
clinical or epidemiological studies.
As Southeast Asia grows as a prominent tourist destination for a
variety of urban and ecotourism activities that have the potential risk of
exposure to Rickettsia spp. vectors, it is expected that the incidence of
imported rickettsial diseases will increase in the coming years [6].
Recently, southeast Asia ranked as the 2nd most common destination
visited by ill returned travelers [14]. When a diagnosis was made (up to
75%), the most common causes of febrile illnesses in travelers returning
from southeast Asia included malaria, dengue and typhoid fever,
justifying an accurate exclusion of these infections, such as what was
performed in this case. Rickettsial infections are also frequent identiﬁ-
able causes of systemic febrile illness in returned travelers, although
these are mainly caused by spotted fever group rickettsia (72%)
[15–17]. This highlights the importance of the knowledge on the world
epidemiology of infectious diseases when approaching the returned
traveler with fever.
Although endemic in Southeast Asia, murine typhus is rarely
diagnosed in the returning traveler, mainly due to an non-speciﬁc
self-limited presentation and lack of diagnostic capacities of most
hospitals. Even though a benign presentation is the rule, murine typhus
may also complicate with organ failure and lead to death, especially if
correct treatment is not started. This highlights the importance of the
knowledge on the world epidemiology of infectious diseases when
approaching the returned traveler with fever.
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